ABEO vs NOC · rev $20.1M vs P/E 17, rev $20.76B
Abeona Therapeutics Inc (ABEO) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
ABEO currently screens at market cap $301.8M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the ABEO and NOC stock pages for the full models.
Not investment advice.